Focused on game changing businesses and go to market innovation, helping companies drive better commercial results through insights driven portfolio strategies (revenue), streamlining of marketing & sales activities (sales velocity) and personalized customer engagement (tactical ROI).

Outset is transforming the lives of dialysis patients who deserve better in an industry that hasn't gained much innovation in decades. For the first time, home hemodialysis is simplified and easier, thanks to Tablo. The journey to adoption is complex - we’re not just selling a dialysis machine but rather supporting home dialysis programs and equipping their care of chronic patients at home. Championing the home business, I lead the strategic plan in partnership with Home cross-functional leaders and relentlessly pursue the rapid expansion of dialysis programs and home patients joining Tablo Nation. As head of home marketing, I oversee execution to expand the provider universe, drive a home-first mindset within care teams, optimize campaigns that activate consumers, help accelerate the referral to home process and support retention of patients. Guiding the team, creative approaches are encouraged, KPIs are examined, and iterating improvements are expected. Driving the business urgently so "Better Begins Now" for all dialysis patients.

Commercial leadership for $200MM+ business in high growth, highly under-penetrated space helping patients self manage their lymphedema with an at-home therapy system. Delivered strong growth despite the pandemic impact to access - adapting account development, advancing industry education and most importantly, evolving delivery of the prescriber and patient experience through a complex DME value chain of marketing, sales, order processing, payer relations, operations and training.

Led teams identifying, developing & commercializing novel products and solutions to unlock new markets, increase customer value, streamline operations and optimize revenue within commercial franchises and supply chain teams. EXECUTIVE LEADERSHIP | STRATEGIC PLANNING & EXECUTION | INFLUENCE• Led cross-functional executive team to develop, align and deliver business integration roadmap; refined market model, identified capabilities investments, prioritized portfolio projects to return business to profitable and grow at 3x market rate.• Secured $2M in Integration funds to develop commercial capabilities, improve the enterprise customer experience, and drive customer acquisition & retention.MARKET OPPORTUNITIES IDENTIFICATION | INNOVATIVE SOLUTIONS• Transformed $56M Sustainability franchise from stand-alone business to integrated portfolio offering embedded in franchise teams across J&J. • Shaped VOC Insights Research identifying three critical Go to Market strategies to activate positioning projected to triple J&J customer preference over competition.• Translated Global Supply Chain Customer Insights Program findings into suite of enterprise solutions. COMMERCIAL EXECUTION | INTEGRATED COMMUNICATIONS• Established customer experience journey for reprocessing to identify crucial moments & opportunities for activation, reframed value prop supported by competitive clinical, operational & economic proof points and developed multi-channel communications plan.• Directed integrated communications plan with complexity of opco, COE and enterprise touchpoints. Oversaw new product launches, program optimization, segmentation, targeting & metrics. EP franchise grew 68% in 1st year of integration. • Scaled Supply Chain Insights Program from 15 - 21 countries (40%) and 458 to 1,212 respondents (248%). Activated Customer Experience improvements through 200+ workshops in 15 countries with 450+ customer engagements annually.

LAUNCH EXCELLENCE | STRATEGIC PLANNING & EXECUTIONDirected enterprise launch excellence and marketing/sales automation to deliver flawless execution for Energy & Endo-Mechanical franchises, $4.7B business providing devices used for surgical procedures.• Uncovered $28M opportunity within 35 procedures to drive incremental revenue for 9 new product launches in one year.• Set launch excellence standards for procedural targeting, talk track & sales tools by leveraging physician research, field sales input, and marketing materials usage rates, content and vehicles.• Established global brand and digital sales resource capability via Sales Materials and Resource Tools (SMART) system desktop application. Managed team and $2M budget.• Launched cross franchise “Promotional Overlay” Program. Increased system selling efficiency: targeting, talk track / messaging and application of sales tools. 81% of sales rep reported sales calls were more effective due to SMART system.GLOBAL MARKETING PRODUCT LAUNCH | CROSS-FUNCTIONAL TEAM LEADERSHIPLed Sedation marketing team and commercial plan for launch of SEDASYS System, a 510k device and first-of-its kind computer assisted personalized sedation technology. FDA panel & PMA approval and launch optimized leveraging efficient marketing, brand and KOL management.• Shaped and delivered commercialization strategy, branding, integrated communications and sales tools to drive the optimal customer experience and secure business results through 12 member team and $4M budget.• Managed brand leadership and stakeholder influence: advisory boards, trade shows, education, PR, media monitoring, digital, issues management and integrated communications.• Optimized team performance through leverage of talent development tools Gallup Q12, Myers Briggs, DISC and StrengthsFinder.

BSC is a leading medical device manufacturer for interventional medical specialties, including cardiology, neuromodulation, electrophysiology, vascular surgery, endoscopy, oncology, urology and gynecology.Led innovative product launches for $843MM Endoscopy business dedicated to delivering solutions to detect and treat less invasive devices for gastrointestinal conditions.• Oversaw Boston Scientific’s first direct to patient initiative, integrating patient, referring physician and physician customer (GI) marketing for launch of endoluminal therapy to treat gastroesophageal reflux disease.• Shaped integrated marketing plan including society influence strategy, limited launch sites, physician product feedback, in-service tools, practice marketing kits, sales training materials, web sites, online advertising, and metrics/reporting tools. Exceeded patient direct marketing response rate goal by 30% with quality of leads at 88%, refined cost per qualified response to <$4. Delivered 20% increase patient referrals to GIs over prior year.• Led commercialization of next generation WallFlex stent platform championing voice of customer on product attributes, positioning, sales approach and marketing tactics to accelerate adoption from trial through loyalty.• Fostered key opinion leader physician relationships, managed staff and drove cross-functional priorities with sales training, regulatory, clinical, marketing science, communications and R&D. Grew enteral stent franchise 23% over prior year, and ASP 46% through the successful pricing, positioning and targeting execution.

Evantage is a boutique healthcare and health technology consulting firm that engages with clients as proven partners in unraveling and solving strategic, operational and customer experience challenges. Provided services in business strategy, market research, digital communications, consumer acquisition, persistency programs, channel promotion, metrics analysis, process improvement and training. • Shaped market development strategies leveraging primary and secondary research, established target audience segments and identified desired “order of conversation”, deployed tactics to motivate behavior at each stage of the customer experience, leveraged KPIs to refined and improve acquisition & retention results.• Delivered integrated communications plan to activate patients and physicians; brochures, in-service tools, sales force, digital consumer web sites, physician portals, email, key words, banner ads, search optimization, affiliate sites.• Developed disease and product focused campaigns to help patients identify their risk of medical conditions and motivate physicians to recommend therapy options. Reduced cost per acquisition of online respondents to one third of original benchmark while maintaining desired site visitor volume and conversion behavior goals.